News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shah Vinay
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4/A
| Shah Vinay (CFO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.99, valued at
$99k
|
|
| 01/25/2022 |
4
| Shah Vinay (CFO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.18, valued at
$381.5k
|
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Shah Vinay (CFO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Bought 8,000 shares
@ $5.76, valued at
$46.1k
|
|
| 01/24/2020 |
4
| Shah Vinay (CFO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 34,826 options
@ $10.84, valued at
$377.5k
|
|
| 03/04/2019 |
4
| Shah Vinay (CFO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 38,000 options
@ $5.83, valued at
$221.5k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|